Cargando…

Characterization of the Estrogen Response Helps to Predict Prognosis and Identify Potential Therapeutic Targets in Cholangiocarcinoma

Cholangiocarcinoma (CCA) is an aggressive malignancy originating from the epithelium of the bile duct. The prognosis of patients is poor regardless of radical resection and chemoradiotherapy. The current classification and prognostic model of CCA are unable to satisfy the requirements for predicting...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Chenglin, Miao, Ji, Li, Minhuan, Zheng, Qisi, Xu, Feng, Pan, Yiming, Wang, Yizhou, Yang, Zhi, Xia, Xuefeng, Zhu, Hao, Chen, Jie, Bao, Shanhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162778/ https://www.ncbi.nlm.nih.gov/pubmed/35664769 http://dx.doi.org/10.3389/fonc.2022.870840

Ejemplares similares

Extracellular Matrix Characterization in Gastric Cancer Helps to Predict Prognosis and Chemotherapy Response
por: Yang, Zhi, et al.
Publicado: (2021)

An Immunity-Related Gene Model Predicts Prognosis in Cholangiocarcinoma
por: Guo, Han, et al.
Publicado: (2022)

Adjuvant therapy for cholangiocarcinoma after surgery and prognosis factors for cholangiocarcinoma: A single-center retrospective cohort study
por: Sun, Zhongquan, et al.
Publicado: (2023)

Identification of macrophage correlated biomarkers to predict the prognosis in patients with intrahepatic cholangiocarcinoma
por: Xu, Linping, et al.
Publicado: (2022)

Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway
por: Mranda, Geofrey Mahiki, et al.
Publicado: (2022)

Identification of therapeutic targets and prognostic biomarkers in cholangiocarcinoma via WGCNA
por: Xu, Lei, et al.
Publicado: (2022)

Personalized intrahepatic cholangiocarcinoma prognosis prediction using radiomics: Application and development trend
por: Chen, Pengyu, et al.
Publicado: (2023)

Estrogens and Their Receptors in Prostate Cancer: Therapeutic Implications
por: Di Zazzo, Erika, et al.
Publicado: (2018)

HtrA1 suppresses the growth of pancreatic cancer cells by modulating Notch-1 expression
por: Cheng, Hao, et al.
Publicado: (2018)

A Novel Clinical-Radiomics Model Based on Sarcopenia and Radiomics for Predicting the Prognosis of Intrahepatic Cholangiocarcinoma After Radical Hepatectomy
por: Deng, Liming, et al.
Publicado: (2021)

Tumor burden score dictates prognosis of patients with combined hepatocellular cholangiocarcinoma undergoing hepatectomy
por: Deng, Gang, et al.
Publicado: (2023)

Correlation Between Adjuvant Chemotherapy Regimen, Recurrence Pattern and Prognosis of Cholangiocarcinoma After Radical Surgery
por: Rao, Le, et al.
Publicado: (2022)

Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis
por: Wang, Yejinpeng, et al.
Publicado: (2019)

Ellagic acid inhibits the proliferation of human pancreatic carcinoma PANC-1 cells in vitro and in vivo
por: Cheng, Hao, et al.
Publicado: (2017)

Development and validation of machine learning models for predicting prognosis and guiding individualized postoperative chemotherapy: A real-world study of distal cholangiocarcinoma
por: Wang, Di, et al.
Publicado: (2023)

Comparison of Four Lymph Node Stage Methods for Predicting the Prognosis of Distal Cholangiocarcinoma Patients After Surgery
por: Huang, Xiuyi, et al.
Publicado: (2021)

Effect of lymph node resection on prognosis of resectable intrahepatic cholangiocarcinoma: A systematic review and meta-analysis
por: Li, Feiyu, et al.
Publicado: (2022)

An Efficient Nomogram for Discriminating Intrahepatic Cholangiocarcinoma From Hepatocellular Carcinoma: A Retrospective Study
por: Si, Yuan-Quan, et al.
Publicado: (2022)

Progress in Radiotherapy for Cholangiocarcinoma
por: Wang, Ningyu, et al.
Publicado: (2022)

Interventional Treatment for Cholangiocarcinoma
por: Li, Hang, et al.
Publicado: (2021)

Alternative Splicing-Based Differences Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Genes, Immune Microenvironment, and Survival Prognosis
por: Luo, Dingan, et al.
Publicado: (2021)

Are the Immunohistochemistry-Based Biomarkers Helpful for Predicting Prognosis in Patients with Surgically Resected Cholangiocarcinoma?
por: Kim, Dong Uk
Publicado: (2023)

Development and Validation of a Nomogram for Differentiating Combined Hepatocellular Cholangiocarcinoma From Intrahepatic Cholangiocarcinoma
por: Wang, Tao, et al.
Publicado: (2020)

Characterization of chromatin regulators identified prognosis and heterogeneity in hepatocellular carcinoma
por: Dai, Yin-wei, et al.
Publicado: (2022)

Recurrent Intrahepatic Cholangiocarcinoma – Review
por: Bekki, Yuki, et al.
Publicado: (2021)

Novel insights into the intraepithelial spread of extrahepatic cholangiocarcinoma: clinicopathological study of 382 cases on extrahepatic cholangiocarcinoma
por: Nagashima, Daisuke, et al.
Publicado: (2023)

Radiomics Based on Digital Mammography Helps to Identify Mammographic Masses Suspicious for Cancer
por: Wang, Guangsong, et al.
Publicado: (2022)

Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Tumor Burden Score Stratifies Prognosis of Patients With Intrahepatic Cholangiocarcinoma After Hepatic Resection: A Retrospective, Multi-Institutional Study
por: Li, Hui, et al.
Publicado: (2022)

Vascular invasion and lymph node metastasis mediate the effect of CA242 on prognosis in hilar cholangiocarcinoma patients after radical resection
por: Heng, Gang, et al.
Publicado: (2022)

Molecular features and predictive models identify the most lethal subtype and a therapeutic target for osteosarcoma
por: Zheng, Kun, et al.
Publicado: (2023)

ARID1A Variations in Cholangiocarcinoma: Clinical Significances and Molecular Mechanisms
por: Zhao, Shankun, et al.
Publicado: (2021)

Signal Pathway of Estrogen and Estrogen Receptor in the Development of Thyroid Cancer
por: Liu, Jian, et al.
Publicado: (2021)

Prostatic metastasis from intrahepatic cholangiocarcinoma
por: Tosev, Georgi, et al.
Publicado: (2018)

Apolipoprotein B Is Associated With the Microenvironment of Cholangiocarcinoma
por: Xu, Xiaofeng, et al.
Publicado: (2021)

Establishment of an Immune Cell Infiltration Score to Help Predict the Prognosis and Chemotherapy Responsiveness of Gastric Cancer Patients
por: Jiang, Quan, et al.
Publicado: (2021)

Stem signatures associating SOX2 antibody helps to define diagnosis and prognosis prediction with esophageal cancer
por: Peng, Zi-Yang, et al.
Publicado: (2022)

Bile-derived exosome noncoding RNAs as potential diagnostic and prognostic biomarkers for cholangiocarcinoma
por: Pan, Yan, et al.
Publicado: (2022)

A Metastatic Intrahepatic Cholangiocarcinoma With HPCs Features: Report of a Case
por: Fu, Qiang, et al.
Publicado: (2022)

The Chemopreventive Role of β-Elemene in Cholangiocarcinoma by Restoring PCDH9 Expression
por: Wu, Qing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h6depu2ij4ohvcnugmnn3j3aeu